Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration

Purpose: To develop machine learning (ML) models to predict, at baseline, treatment outcomes at month 9 in patients with neovascular age-related macular degeneration (nAMD) receiving faricimab. Design: Retrospective proof of concept study. Participants: Patients enrolled in the phase II AVENUE trial...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yusuke Kikuchi, PhD, Michael G. Kawczynski, MS, Neha Anegondi, MTech, Ales Neubert, PhD, Jian Dai, PhD, Daniela Ferrara, MD, PhD, Carlos Quezada-Ruiz, MD
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2024-03-01
Цуврал:	Ophthalmology Science
Нөхцлүүд:	Machine learning Optical coherence tomography Neovascular age-related macular degeneration Faricimab Treatment
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2666914523001173
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!